Effect of substance P, insulin-like growth factor-1 and vasoactive intestinal polypeptide on corneal re-epithelialization in galactosemic rats

Current Eye Research

Volumn 17, Issue 12, 1998, Pages 1143-1149

  McDermott, Alison M ^a,b   Kern, Timothy S ^b   Reid, Ted W ^c   Russell, Paul ^d   Murphy, Christopher J ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c TEXAS TECH UNIVERSITY   (United States)

^d NATIONAL EYE INSTITUTE   (United States)

Author keywords

Cornea; Galactosemia; Insulin like growth factor 1; Re epithelialization; Substance P; Vasoactive intestinal polypeptide

Indexed keywords

FLUORESCEIN; GALACTOSE; SOMATOMEDIN C; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORNEA EPITHELIUM; EPITHELIZATION; GALACTOSEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031798332     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.17.12.1143.5131     Document Type: Article

References (51)

1. Nilsson J, von Euler AM, Dalsgaard CJ. Stimulation of connective tissue cell growth by substance P and substance K. Nature. 1985;315:61-63.
2. Shih C, Bernard GW. Neurogenic substance P stimulates osteogenesis in vitro. Peptides. 1997;18:323-326.
3. Lotz M, Carson DA, Vaughan JH. Substance P activation of rheumatoid synoviocytes: neural pathways in pathogenesis of arthritis. Science. 1987;235:893-895.
4. Ziche M, Morbidelli L, Pacini M, Geppetti P, Alessandri G, Maggi CA. Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvascular Res. 1990;40:264-278.
5. Villablanca AC, Murphy CJ, Reid TW. Growth-promoting effects of substance P on endothelial cells in vitro: synergism with calcitonin gene-related peptide, insulin, and plasma factors. Circ Res. 1994;75:1113-1120.
6. Tanaka T, Danno K, Ikai K, Imamura S. Effects of substance P and substance K on the growth of cultured keratinocytes. J Invest Dermatol. 1988;90:399-401.
7. Benrath J, Zimmermann M, Gillardon F. Substance P and nitric oxide mediate wound healing of ultraviolet photo-damaged rat skin: evidence for an effect of nitric oxide on keratinocyte proliferation. Neurosci Letts. 1995;200:17-20.
8. Khalil Z, Helme R. Sensory peptides as neuromodulators of wound healing in aged rats. J Gerontol. 1996;51A: B354-B361.
9. Benito M, Valverde AM, Lorenzo M. IGF-1: a mitogen also involved in differentiation processes in mammalian cells. Int J Biochem Cell Biol. 1996;28:499-510.
10. Bitar MS. Insulin-like growth factor-1 reverses diabetes-induced wound healing impairment in rats. Horm Metab Res. 1997;29:383-386.
11. Muller JM, Lelievre V, Becq-Giraudon L, Meunier AC. VIP as a cell-growth and differentiation neuromodulator role in neurodevelopment. Mol Neurobiol. 1995;10:115-134.
12. Waschek JA. VIP and PACAP receptor-mediated actions on cell proliferation and survival. Annals NY Acad Sci. 1996;805:290-300.
13. Haegerstrand A, Jonzon B, Dalsgaard CJ, Nilsson J. Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes. Proc Natl Acad Sci USA. 1989;86:5993-5996.
14. Wollina U, Huschenbeck J, Knoll B, Sternberg B, Hipler UC. Vasoactive intestinal polypeptide supports induced migration of human keratinocytes and their colonization of an artificial polyurethane matrix. Reg Peptides. 1997;70: 29-36.
15. Miller A, Costa M, Furness JB, Chubb IW. Substance P immunoreactive sensory nerves supply the rat iris and cornea. Neurosci Letts. 1981;23:243-249.
16. Sasaoka A, Ichiro I, Kuwayama Y, et al. Overall distribution of substance P nerves in the rat cornea and their three-dimensional profiles. Invest Ophthalmol Vis Sci. 1984;25: 351-356.
17. Stone RA, Kuwayama Y, Laties AM. Regulatory peptides in the eye. Experientia. 1987;43:791-800.
18. 1 receptor and its participation in the synergistic enhance-ment of corneal epithelial migration by substance P and insulin-like growth factor-1. Br J Pharmacol. 1997;120: 546-552.
19. Li DQ, Tseng SC. Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface. J Cell Physiol. 1995;163:61-79.
20. Burren CP, Berka JL, Edmondson SR, Werther GA, Batch JA. Localization of mRNAs for insulin-like growth factor-1 (IGF-1), IGF-1 receptor, and IGF binding broteins in rat eye. Invest Ophthalmol Vis Sci. 1996;37:1459-1468.
21. Denis P, Dussaillant M, Nordmann JP, Elena PP, Saraux H, Rostene W. Autoradiographic characterisation and localization of vasoactive intestinal peptide binding sites in albino rat and rabbit eyes. Exp Eye Res. 1991;52:357-366.
22. Marfurt CF, Echtenkamp SF. The effect of diabetes on neuropeptide content of the rat cornea and iris. Invest Ophthalmol Vis Sci. 1995;36:1100-1106.
23. Beuerman RW, Schimmelpfennig B. Sensory denervation of the rabbit cornea affects epithelial properties. Exp Neurol. 1980;69:196-201.
24. Araki K, Ohashi Y, Kinoshita S, Hayashi K, Kuwayama Y, Tano Y Epithelial wound healing in the denervated cornea. Curr Eye Res. 1994;13:203-211.
25. Gallar J, Pozo MA, Rebollo I, Belmonte C. Effects of capsaicin on corneal wound healing. Invest Ophthalmol Vis Sci. 1990;31:1968-1974.
26. Murphy CJ, Mannis MJ, Malfroy B, Reid TW. Neuropeptide depletion impairs corneal epithelial wound healing. Invest Ophthalmol Vis Sci. 1990;31:55.
27. Reid TW, Murphy CJ, Iwahashi CK, Foster BA, Mannis MJ. Stimulation of epithelial cell growth by the neuropeptide substance P. J Cell Biochem. 1993;52:476-485.
28. Nishida T, Nakamura M, Ofuji K, Reid TW, Mannis MJ, Murphy CJ. Synergistic effect of substance P with insulin-like growth factor-1 on epithelial migration of the cornea. J Cell Physiol. 1996;169:159-166.
29. Nakamura M, Ofuji K, Chikama T, Nishida T. Combined effects of substance P and insulin-like growth factor-1 on corneal epithelial wound closure of rabbit In vivo. Curr Eye Res. 1997;16:275-278.
30. Kingsley RE, Marfurt CF. Topical substance P and corneal epithelial wound closure in the rabbit. Invest Ophthalmol Vis Sci. 1997;38:388-395.
31. Brown SM, Lamberts DW, Reid TW, Nishida T, Murphy CJ. Neurotrophic and anhidrotic keratopathy treated with substance P and insulin-like growth factor-1. Arch Ophthalmol. 1997;115:926-927.
32. Nakamura M, Nishida T, Ofuji K, Reid TW, Mannis MJ, Murphy CJ. Synergistic effect of substance P with epidermal growth factor on epithelial migration in rabbit cornea. Exp Eye Res. 1997;65:321-329.
33. Fukushi S, Merola LO, Tanaka M, Datiles M, Kinoshita JH. Re-epithelialization of denuded corneas in diabetic rats. Exp Eye Res. 1980;31:611-621.
34. Crouch ER III, Breazeale RI, Crouch ER Jr, Davidson JC, Lattanzio FA, Williams PB. Corneal wound healing in a diabetic rabbit model. Invest Ophthalmol Vis Sci. 1997;38s:403.
35. Datiles AB, Kador PF, Fukui HN, Hu TS, Kinoshita JH. Corneal re-epithelialization in galactosemic rats. Invest Ophthalmol Vis Sci. 1983;24:563-569.
36. Herse PR. A review of manifestations of diabetes mellitus in the anterior eye and cornea. Am J Optom Physiol Optics. 1988;65:224-230.
37. Rosenberg CS. Wound healing in the patient with diabetes mellitus. Nursing Clin North America. 1990;25:247-261.
38. Parrish CM. The cornea in diabetes mellitus. In: Feman SS. Ocular Problems in Diabetes Mellitus. Boston: Blackwell Scientific Publications; 1992:179-205.
39. Crosson CE, Klyce SD, Bauerman RW. Epithelial wound closure in the rabbit cornea: a biphasic process. Invest Ophthalmol Vis Sci. 1986;27:464-473.
40. Hughes A. A schematic eye for the rat. Vision Res. 1979; 19:569-588.
41. Murphy CJ, Russell P, Reid TW. Substance P accelerates corneal epithelial wound healing of galactosemic rats. Invest Ophthalmol Vis Sci. 1995;36s:572.
42. Zieske JD, Wasson M. Regional variation in distribution of EGF receptor in developing and adult corneal epithelium. J Cell Sci. 1993;106:145-152.
43. Sandvig KU, Haaskjold E, Bjerknes R, Refsum SB, Kravik K. Cell kinetics of conjunctival and corneal epithelium during regeneration of different-sized corneal epithelial defects. Acta Ophthalmol. 1994;72:43-48.
44. Schwartz DE. Corneal sensitivity in diabetics. Arch. Ophthalmol. 1974;91:174-178.
45. Jacot JL, Hosotani H, Glover JP, Lois N, Robison WG. Diabetic-like corneal sensitivity loss in galactose-fed rats ameliorated with aldose reductase inhibitors. J Ocular Pharm Thera. 1998;14:169-180.
46. Crowe R, Burnstock G. An increase of vasoactive intestinal polypeptide-, but not neuropeptide Y-, substance P- or catecholamine-containing nerves in the iris of the streptozotocin-induced diabetic rat. Exp Eye Res. 1988;47:751-759.
47. Lindberger M, Schroder HD, Schultzberg M, et al. Nerve fibre studies in skin biopsies in peripheral neuropathies, I: immunohistochemical analysis of neuropeptides in diabetes mellitus. J Neurol Sci. 1989;93:289-296.
48. Rittenhouse PA, Markle RA, Marchand JE, Kream RM, Leeman SE. Streptozotocin-induced diabetes produces a decrease in pituitary substance P content and preprotachykinin mRNA. Neurosci Letts. 1996;211:77-80.
49. Lowe WL, Florkiewicz RZ, Yorek MA, Spanheimer RG, Albrecht BN. Regulation of growth factor mRNA levels in the eyes of diabetic rats. Metab Clin Exp. 1995;44:1038.
50. Bornfeldt KE, Skottner A, Arnqvist HJ. In vivo regulation of messenger RNA encoding insulin-like growth factor-I (IGF-I) and its receptor by diabetes, insulin and IGF-I in rat muscle. J Endocrinol. 1992;135:203-211.
51. Rodriguez-Pena MS, Guijarro LG, Juarranz MG, Rodriguez-Henche N, Bajo AM, Aguado F, Prieto JC. Analysis of vasoactive intestinal peptide receptors and the G protein regulation of adenylyl cyclase in seminal vesicle membranes from streptozotocin-diabetic rats. Cell Signal. 1994; 6:147-156.